Traditional Chinese medicine composition for treating upper respiratory tract infection

Abstract

The invention discloses a traditional Chinese medicine composition for treating upper respiratory tract infection. The traditional Chinese medicine composition comprises, by weight, 20-25 parts of flos lonicerae, 3-4 parts of folium mori, 1-3 parts of herba schizonepetae spike, 3-4 parts of folium eriobotryae, 2-4 parts of endothelium corneum gigeriae galli, 5-6 parts of periostracum cicadae, 6-8 parts of ramulus uncariae cum uncis, 4-5 parts of verbena officinalis, 2-3 parts of folium pyrrosiae, 15-20 parts of fructus momordicae, 10-12 parts of rhizoma imperatae, 4-6 parts of fructus leonuri, 2-4 parts of processed rhizoma pinelliae, 5-6 parts of radix rehmanniae, 3-4 parts of semen malvae, 5-8 parts of radix salviae miltiorrhizae, 2-4 parts of radix et caulis acanthopanacis senticosi, 4-5 parts of radix stellariae, 5-8 parts of flos eriocauli, 2-4 parts of viola persicifolia leaves and 1-3 parts of castanopsis chinensis hance leaves. The traditional Chinese medicine composition has the advantages that the traditional Chinese medicine composition is made of natural traditional Chinese medicines and is free of toxic and side effects, definite curative effects can be realized, and the upper respiratory tract infection can be effectively cured and is difficult to recur; effects of clearing heat, cooling blood, discharging fire, enriching the blood, enriching and nourishing yin, generating body fluid, promoting blood and qi circulation and inducing diuresis for removing edema can be realized, the traditional Chinese medicine composition is free of medicine resistance and side effects and high in effective rate and safety, the broad curative effects can be realized, and the like.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition for treating upper respiratory tract infection, which belongs to the field of traditional Chinese medicines. Background technique [0002] Upper respiratory tract infection is one of the common human diseases, mostly occurs in spring and winter, regardless of age, sex, occupation, region, people with low immune function are susceptible, 70%-80% are caused by viruses, 20%-30% are caused by bacteria Symptoms mainly include fever, nasal congestion, cough, headache, sore throat, myalgia, fatigue, etc.; for upper respiratory tract infection, the general Western medicine treatment is oral antibiotics or intravenous antibiotic infusion, but frequent use of antibiotics will lead to drug resistance Therefore, while the patient's condition is under certain control, the immunity is deteriorating, and complications are prone to occur. Contents of the invention [0003] The object of the present...

AI Technical Summary

Problems solved by technology

[0002] Upper respiratory tract infection is one of the common human diseases, mostly occurs in spring and winter, regardless of age, sex, occupation, region, people with low immune function are susceptible, 70%-80% are caused by viruses, 20%-30% are caused by bacteria Symptoms mainly include fever, nasal congestion, cough, headache, sore throat, myalgia, fatigue, etc.; for upper respiratory tract infection, the general Western medicine treatment is oral antibiotics or intravenous antibiotic infusion, but frequent use of antibiotics will lead to drug resistance , so while the patient's condition is under certain control, the immune system is getting worse, and complications are prone to occur